Director Clinical Operations
Helene Muller has over 25 years of experience in the pharmaceutical industry managing numerous clinical projects for leading clinical research organizations but also working as a consultant supporting mainly small and mid-sized biotechnology companies in project oversight and implementation.
Dr. Nadezda Gracheva
Clinical Research Scientist
Dr. Nadezda Gracheva is a scientist with a background in Radiochemistry and Radiopharmacy as a branch of Nuclear Medicine. She obtained a Ph.D. degree at ETH Zurich, where she was responsible for the development of novel radioactive nuclides for Targeted Radionuclide Therapy to promote innovative cancer treatments.
Dr. Philip V’kovski
Dr. Philip V’kovski is a virologist and has experience in studying animal and human coronaviruses. Philip holds an M. Sc degree in Infection and Immunity from Utrecht University and obtained his Ph.D. degree from the University of Bern for his studies of molecular interactions at the coronavirus replication complex.
Dr. Nina Orlova-Fink
Nina is an immunologist with 15 years of broad experience in infectious diseases and virology. She joined RocketVax from the Swiss Tropical and Public Health Institute, where she investigated the phenotypic and functional characteristics of cellular responses induced by a malaria vaccine candidate in clinical settings.